Vicore Pharma Holding AB
VCRE | NASDAQ
$9.89
+$0.09 (+0.92%)
Nov 2, 2026, 12:37 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.33M | 2.85M | 3.14M | 3.18M | 3.1M | 1.35M | 10.22M | 9.76M | 9.76M | 9.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | 554.32K | 1.39M | 1.39M | 52.47M | 52.75M | 52.76M | 53.65M | 3.46M | 3.52M | 3.58M | 3.58M | 2.7M | 2.7M | 1.8M | 899.55K | 899.55K |
Gross Profit | 1.33M | 2.85M | 3.14M | 3.18M | 2.54M | -33.93K | 8.84M | -42.7M | -42.99M | -42.99M | -53.65M | -3.46M | -3.52M | -3.58M | -3.58M | -2.7M | -2.7M | -1.8M | -899.55K | -899.55K |
Operating Income | -285.35M | -381.04M | -348.74M | -223.54M | -389.29M | -456.22M | -534.65M | -828.86M | -947.51M | -1.07B | -1.19B | -1.16B | -1.13B | -1.1B | -1.08B | -817.97M | -560.7M | -292.2M | -20.13M | -11.17M |
Interest Income | 21.37M | 31.68M | 22.14M | 17.51M | 17.26M | 7.58M | 1.96M | 2.32M | 2.44M | 1.85M | 1.06M | 292.87K | 261.67K | 215.31K | 215.31K | 466.95K | 380.17K | 380.17K | 380.17K | 10.17K |
Pretax Income | -272.4M | -373.05M | -376.05M | -246.55M | -393.42M | -436.4M | -474.93M | -760.01M | -888.48M | -1.02B | -1.16B | -1.13B | -1.11B | -1.09B | -1.07B | -812.68M | -557.25M | -290.39M | -20.04M | -11.16M |
Net Income | -272.5M | -373.13M | -376.05M | -246.55M | -293.73M | -183.68M | -69.18M | 489.78M | 543.19M | 542.09M | 532.74M | -77.87M | -78.22M | -78.24M | -164.48M | -114.12M | -205.13M | -198.7M | -106.07M | -97.18M |
Selling & General & Admin | 48.85M | 59.53M | 52.14M | 31.61M | 40.49M | 39.03M | 34.86M | 49.8M | 49.41M | 45.58M | 44.41M | 35.58M | 26.06M | 27.12M | 28.68M | 21.75M | 21.58M | 11.74M | 1.39M | 676.15K |
Research & Development | 238.42M | 325.58M | 301.72M | 196.05M | 233.84M | 183.24M | 172.32M | 217.47M | 223.42M | 233.9M | 221.46M | 221.6M | 172.76M | 166.98M | 190.55M | 146.1M | 151.14M | 97.6M | 18.67M | 10.45M |
Other Expenses | -597.93K | -1.22M | -1.98M | -948.31K | -938.97K | -359.97K | -70.11M | -70.17M | -70.17M | -70.17M | n/a | n/a | 62.3M | 62.3M | 62.3M | 62.33M | 85.04M | 85.04M | 85.04M | 85M |
Operating Expenses | 286.68M | 383.89M | 351.88M | 226.72M | 273.39M | 221.91M | 137.07M | 197.1M | 202.65M | 209.31M | 265.87M | 257.19M | 261.12M | 256.4M | 281.53M | 230.18M | 257.76M | 194.38M | 105.1M | 96.13M |
Interest Expense | 9.19M | 23.69M | 49.45M | 40.91M | 40.91M | 26.41M | n/a | n/a | n/a | n/a | 28.81K | 28.81K | 28.81K | 137.21K | 139.98K | 139.98K | 139.98K | 31.58K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 183.75K | 378.45K | 557.76K | 727.13K | 694.42K | 647.76K | 736.57K | 906.08K | 910.24K | 762.21K | 494.09K | 155.21K | n/a |
Cost & Expenses | 286.68M | 383.89M | 351.88M | 226.72M | 220.24M | 113.28M | 28.44M | 322.19M | 612.98M | 904.25M | 1.19B | 1.16B | 1.13B | 1.1B | 1.08B | 817.97M | 560.7M | 292.2M | 20.13M | 11.17M |
Income Tax Expense | 103.84K | 86K | n/a | n/a | -63.24K | -158.53K | -255.19K | -350.61K | -383.42K | -383.83K | -382.51K | -380.81K | -380.76K | -380.83K | -380.71K | -277.27K | -294.83K | -199.07K | -103.83K | -113.56K |
Shares Outstanding (Basic) | 280.09M | 28.15M | 25.58M | 234.61M | 23.46M | 23.46M | 216.05M | 111.73M | 111.73M | 111.72M | 111.72M | 108.77M | 81.85M | 81.85M | 73.49M | 71.85M | 71.76M | 71.76M | 71.76M | 71.76M |
Shares Outstanding (Diluted) | 280.09M | 28.15M | 25.58M | 234.61M | 23.46M | 23.46M | 216.05M | 111.73M | 111.73M | 111.72M | 111.72M | 108.77M | 81.85M | 81.85M | 73.49M | 71.85M | 71.76M | 71.76M | 71.76M | 71.76M |
EPS (Basic) | -9.40 | -14.25 | -15.15 | -9.79 | -9.79 | -4.94 | -0.11 | -0.17 | -0.17 | -0.20 | -0.31 | -0.29 | -0.32 | -0.33 | -0.39 | -0.44 | -0.51 | -0.42 | -0.28 | -0.16 |
EPS (Diluted) | -9.40 | -14.25 | -15.15 | -9.79 | -9.79 | -4.94 | -0.11 | -0.17 | -0.17 | -0.20 | -0.31 | -0.29 | -0.32 | -0.33 | -0.39 | -0.44 | -0.51 | -0.42 | -0.28 | -0.16 |
EBITDA | -248.71M | -349.57M | -326.82M | -206.71M | -200.33M | -105.3M | -166.64M | -448.72M | -447.65M | -448.14M | -307.9M | -23.29M | -24.66M | -24.53M | -27.88M | -30.81M | -35.66M | -29.45M | -19.88M | -11.03M |
EBIT | -264.25M | -349.63M | -326.88M | -206.77M | -200.38M | -161.79M | -225.23M | -509.4M | -568.92M | -575.58M | -492.06M | -260.64M | -201.43M | -196.78M | -221.91M | -169.65M | -260.42M | -196.14M | -105.96M | -97.03M |
Depreciation & Amortization | 15.54M | 59.56K | 59.56K | 59.83K | 55.52K | 134.69K | 2.24M | 4.33M | 5.45M | 5.44M | 3.42M | 1.43M | 332.69K | 343.17K | 352.19K | 339.05K | 360.86K | 272.59K | 176.57K | 103.17K |
Add to Watchlist
Select watchlists to add or remove VCRE